These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16982794)

  • 1. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.
    Kornbluth RS; Smee DF; Sidwell RW; Snarsky V; Evans DH; Hostetler KY
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4038-43. PubMed ID: 16982794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of cidofovir resistant vaccinia viruses.
    Becker MN; Obraztsova M; Kern ER; Quenelle DC; Keith KA; Prichard MN; Luo M; Moyer RW
    Virol J; 2008 May; 5():58. PubMed ID: 18479513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice.
    Smee DF; Wandersee MK; Bailey KW; Hostetler KY; Holy A; Sidwell RW
    Antivir Chem Chemother; 2005; 16(3):203-11. PubMed ID: 16004083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.
    Andrei G; Gammon DB; Fiten P; De Clercq E; Opdenakker G; Snoeck R; Evans DH
    J Virol; 2006 Oct; 80(19):9391-401. PubMed ID: 16973545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
    Quenelle DC; Collins DJ; Kern ER
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
    Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.
    Gammon DB; Snoeck R; Fiten P; Krecmerová M; Holý A; De Clercq E; Opdenakker G; Evans DH; Andrei G
    J Virol; 2008 Dec; 82(24):12520-34. PubMed ID: 18842735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 3'-to-5' exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.
    Gammon DB; Evans DH
    J Virol; 2009 May; 83(9):4236-50. PubMed ID: 19224992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.
    Duraffour S; Andrei G; Topalis D; Krečmerová M; Crance JM; Garin D; Snoeck R
    J Virol; 2012 Jul; 86(13):7310-25. PubMed ID: 22532673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
    Smee DF; Bailey KW; Sidwell RW
    Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice.
    Smee DF; Dagley A; Downs B; Hagloch J; Tarbet EB
    Antimicrob Agents Chemother; 2015 Jan; 59(1):520-6. PubMed ID: 25385098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
    Smee DF; Wong MH; Bailey KW; Beadle JR; Hostetler KY; Sidwell RW
    Int J Antimicrob Agents; 2004 May; 23(5):430-7. PubMed ID: 15120719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir.
    Kinchington PR; Araullo-Cruz T; Vergnes JP; Yates K; Gordon YJ
    Antiviral Res; 2002 Oct; 56(1):73-84. PubMed ID: 12323401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
    Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
    James SH; Price NB; Hartline CB; Lanier ER; Prichard MN
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3321-5. PubMed ID: 23650158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
    Smee DF; Bailey KW; Wong MH; Sidwell RW
    Antiviral Res; 2001 Oct; 52(1):55-62. PubMed ID: 11530188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances.
    Smee DF; Bailey KW; Wong MH; Tarbet EB
    Antivir Chem Chemother; 2011 May; 21(5):201-8. PubMed ID: 21566266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
    Smee DF; Bailey KW; Sidwell RW
    Antivir Chem Chemother; 2001 Jan; 12(1):71-6. PubMed ID: 11437324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility to ST-246 and Cidofovir corroborates the phylogenetic separation of Brazilian Vaccinia virus into two clades.
    Pires MA; Rodrigues NFS; de Oliveira DB; de Assis FL; Costa GB; Kroon EG; Mota BEF
    Antiviral Res; 2018 Apr; 152():36-44. PubMed ID: 29427676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.